Name | Vitamin D3 receptor | ||
UniProt ID | VDR_HUMAN | ||
Gene Name | VDR | ||
Gene ID | 7421 | ||
Synonyms |
VDR, NR1I1, PPP1R163
|
||
Sequence |
MEAMAASTSLPDPGDFDRNVPRICGVCGDRATGFHFNAMTCEGCKGFFRRSMKRKALFTC
PFNGDCRITKDNRRHCQACRLKRCVDIGMMKEFILTDEEVQRKREMILKRKEEEALKDSL RPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSHPSRPNSRHTPSFSG DSSSSCSDHCITSSDMMDSSSFSNLDLSEEDSDDPSVTLELSQLSMLPHLADLVSYSIQK VIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDV TKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLS NTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLE VFGNEIS |
||
Pathway Map | MAP LINK | ||
T.C. Number | 9.B.208.1.1 | ||
KEGG ID | hsa7421 | ||
TTD ID | T34234 | ||
Pfam | PF00104; PF00105 |
Pair Name | Bufalin, 1,25-dihydroxyvitamin D3 | |||
Phytochemical | Bufalin | |||
Drug | 1,25-dihydroxyvitamin D3 | |||
Disease Info | [ICD-11: 2A60.Z] | Acute myeloid leukemia | Investigative | |
Regulate Info | Up-regulation | Vitamin D3 receptor | Expression | |
Result | The Na(+),K(+)-ATPase inhibitor bufalin modulates VDR function through several mechanisms, including Erk MAP kinase activation and increased nuclear VDR expression. |